Skip to main content
John Wagner, MD, Pediatric Hematology & Oncology, Minneapolis, MN

John E Wagner MD


Professor, Pediatrics, University of Minnesota Medical School, Minneapolis

Join to View Full Profile
  • 516 Delaware St SEPWB Fifth floor Suite 5100 Clinic 5BMinneapolis, MN 55455

  • Phone+1 612-626-2663

  • Fax+1 612-626-4074

Dr. Wagner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1984 - 1987
  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1981 - 1984
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1991 - 2025
  • MD State Medical License
    MD State Medical License 1984 - 1991
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2000
  • Elected Member American Association of Physicians

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
    John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Uni...
    John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Romiplostim Improves Platelet Recovery after UCB Transplant
    John E. Wagner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Top Doctors: A Legacy of Discovery
    Top Doctors: A Legacy of DiscoveryJuly 1st, 2021

Grant Support

  • Inducible Regulatory T Cells for the Prevention and Treatment of GVHDNational Heart, Lung and Blood Institute2012–Present
  • First in Human Study to Evaluation the Safety and Tolerability of HSC835Novartis2011–Present
  • Production Assistance for Cellular TherapiesNational Heart, Lung and Blood Institute2003–Present
  • Biology and Transplantation of the Human Stem CellNational Cancer Institute1997–Present

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: